Integrate SmartSignals Solutions into Your Non-Small Cell Lung Cancer Research Date Published: Feb 19, 2021 Video Streamline your non-small cell lung cancer cancer (NSCLC) clinical research cancer with Signant’s electronic solutions and team of experts. With years of experience supporting oncology trials like yours, we guide you with best practices to help you reach your goal. Try our solutions below in your next NSCLC study: Pre-configured eCOA eConsent Sensors & Wearables Randomization & Trial Supply Management (RTSM) With industry-leading cyber security, we protect the collected data throughout the entire process. Share: LinkedInTweet Recommended Resources Non-Small Cell Lung Cancer Solutions Download Now Brochure Biotech Better: Solutions for Emerging Biotech/Biopharma Trials Download Now Brochure Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now